Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNF╬▒, induces robust activation and a phenotypic switch of ILC3.

Paustian AMS, Paez-Cortez J, Bryant S, Westmoreland S, Waegell W, Kingsbury G.

PLoS One. 2017 Aug 8;12(8):e0182841. doi: 10.1371/journal.pone.0182841. eCollection 2017.

2.

A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection.

Stachlewitz RF, Hart MA, Bettencourt B, Kebede T, Schwartz A, Ratnofsky SE, Calderwood DJ, Waegell WO, Hirst GC.

J Pharmacol Exp Ther. 2005 Oct;315(1):36-41. Epub 2005 Jul 12.

PMID:
16014572
3.

A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection.

Borhani DW, Calderwood DJ, Friedman MM, Hirst GC, Li B, Leung AK, McRae B, Ratnofsky S, Ritter K, Waegell W.

Bioorg Med Chem Lett. 2004 May 17;14(10):2613-6.

PMID:
15109663
4.

A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection.

Waegell W, Babineau M, Hart M, Dixon K, McRae B, Wallace C, Leach M, Ratnofsky S, Belanger A, Hirst G, Rossini A, Appel M, Mordes J, Greiner D, Banerjee S.

Transplant Proc. 2002 Aug;34(5):1411-7. No abstract available.

PMID:
12176420
6.

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.

Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W.

J Exp Med. 1996 Jun 1;183(6):2605-16.

8.
9.

Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta.

Waegell WO, Higley HR, Kincade PW, Dasch JR.

Exp Hematol. 1994 Oct;22(11):1051-7.

PMID:
7925771
11.

Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.

Snapper CM, Waegell W, Beernink H, Dasch JR.

J Immunol. 1993 Nov 1;151(9):4625-36.

PMID:
8409423
12.

Transforming growth factor beta 1 (TGF-beta 1) receptor expression on resting and mitogen-activated T cells.

Ellingsworth L, Nakayama D, Dasch J, Segarini P, Carrillo P, Waegell W.

J Cell Biochem. 1989 Apr;39(4):489-500.

PMID:
2785999
13.
14.

Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation.

Ellingsworth LR, Nakayama D, Segarini P, Dasch J, Carrillo P, Waegell W.

Cell Immunol. 1988 Jun;114(1):41-54.

PMID:
2897247
15.

The use of congenital immunologic mutants to probe autoimmune disease in New Zealand mice.

Waegell WO, Gershwin ME, Castles JJ.

Prog Clin Biol Res. 1987;229:175-97.

PMID:
2955425

Supplemental Content

Loading ...
Support Center